Calithera Biosciences, Inc. CALA

Set alert

0.00 USD 0.00 0.00%

At close · Oct 30

0.0001 Day range 0.0001

0.0001 52-week range 0.001

More statistics

Price target (mean) 5.00 +4999900.0% upside

Now 0.0001

Ratings (0m) 5 4 buy · 1 hold · 0 sell

CALA analyst estimates
Period	EPS estimate	Low – high	Year ago	EPS growth	Revenue growth	Analysts
Current quarter	-1.49	-1.49 – -1.49	-4.80	+69.0%	0.0%	1
Next quarter	-0.52	-0.52 – -0.52	-3.60	+85.6%	0.0%	1
Current year	-8.62	-8.62 – -8.62	-17.40	+50.5%	0.0%	1
Next year	-1.35	-1.35 – -1.35	-8.62	+84.3%	0.0%	1

CALA analyst upgrades and downgrades
Date	Firm	Action	From	To
Nov 15, 2022	Ladenburg Thalmann	Downgrade	Buy	Neutral
Nov 15, 2022	SVB Leerink	Downgrade	Outperform	Market Perform
Aug 29, 2022	HC Wainwright & Co.	Upgrade	Neutral	Buy
Aug 16, 2022	SVB Leerink	Maintained	—	Outperform
May 11, 2022	Wells Fargo	Maintained	—	Equal-Weight
Apr 4, 2022	SVB Leerink	Maintained	—	Outperform
Jan 31, 2022	Ladenburg Thalmann	Initiated	—	Buy
Jan 20, 2022	SVB Leerink	Upgrade	Market Perform	Outperform
Nov 8, 2021	HC Wainwright & Co.	Downgrade	Buy	Neutral
Nov 5, 2021	William Blair	Downgrade	Outperform	Market Perform
Jan 5, 2021	HC Wainwright & Co.	Maintained	—	Buy
Jan 5, 2021	SVB Leerink	Downgrade	Outperform	Market Perform
Aug 11, 2020	SVB Leerink	Maintained	—	Outperform
May 8, 2020	HC Wainwright & Co.	Reiterated	—	Buy
Mar 27, 2020	Citigroup	Maintained	—	Buy
Mar 27, 2020	Jefferies	Initiated	—	Buy
Nov 19, 2019	H.C. Wainwright	Initiated	—	Buy
Feb 16, 2018	Citigroup	Upgrade	Neutral	Buy
Oct 5, 2017	William Blair	Initiated	—	Outperform
Mar 28, 2017	H.C. Wainwright	Maintained	—	Buy
Jan 24, 2017	Citigroup	Upgrade	Sell	Neutral
Oct 25, 2016	Citigroup	Initiated	—	Sell
Mar 9, 2016	JMP Securities	Maintained	—	Market Outperform
Jul 24, 2015	Citigroup	Initiated	—	Buy
Jan 28, 2015	Citigroup	Maintained	—	Buy
Oct 27, 2014	Citigroup	Initiated	—	Buy
Oct 27, 2014	Wells Fargo	Initiated	—	Outperform
Oct 27, 2014	Leerink Swann	Initiated	—	Outperform

Recommendation trend